BILLS-119hr5160ih.pdf - Research Document Archive

Loading OCR text...

DATE (6)

2005 2025 SEPTEMBER 4 each of fiscal years 2027 7 1ST SESSION H. R. 5160 2031

EVENT (1)

the ‘‘Stem Cell

GPE (3)

the United States of America New Jersey 5160 IH

LOC (2)

the Stem Cell Therapeutic and Research Act the Stem Cell Therapeutic and

ORG (11)

SEC the Committee on Energy and Commerce U.S.C. the Public Health Service Act Congress House of Representa- GREE the Stem Cell Therapeutic Senate THE HOUSE OF REPRESENTATIVES

PERSON (6)

kjohnson TENNEY BILIRAKIS MFUME SMITH MATSUI

Topic Classifications

congressional legislation 98.0%

public health 95.1%

government oversight 56.7%

Extracted Keywords

cell stem reauthorize reauthorization act purposes research years sec inventory following fiscal session reauthorize appropriated sec reauthorization blood sep sep sep jkt

Forensic Analysis

PDF Metadata

Creator: U.S. Gov. Printing Office -- G.S.D.D.
ModDate: D:20250909075647Z
Producer: Acrobat Distiller 25.0 (Windows); modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
CreationDate: D:20250909032414-04'00'

Sentiment

Polarity

Neutral

0.092

Subjectivity

46%

Objective

No crisis correlations found for this document.

The ML pipeline may still be processing.